Breast Milk Stem Cell Culture for Customizable Milk-Like Products
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively replicate the complex composition of human milk and produce customized milk products tailored to individual needs, and there is a limited supply of human milk due to regulatory and ethical constraints.
Innovation Solution
A method involving culturing mammalian breast milk stem cells with bone morphogenic protein 4 (BMP4) and retinoic acid (RA) to generate embryoid bodies, which are then grown to produce mammary gland cells capable of secreting a mammalian milk-like product, including human milk, with customizable components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If human milk is obtained from human donors, then the composition is authentic and complete, but the supply is limited and subject to regulatory and ethical constraints
Solution Approach 1:
The patent creates artificial copies of human milk components by culturing breast milk stem cells in vitro to generate mammary gland cells that produce milk proteins, lipids, carbohydrates, and bioactive factors. This copying approach bypasses the need for actual human breast milk donation while replicating its complex composition, thereby increasing supply and enabling customization.
Solution Approach 2:
The patent employs parameter changes by modifying culture conditions (adding BMP4 and RA at specific concentrations and time points) to control the differentiation of stem cells into functional mammary cells. This allows optimization of milk component production and customization of the final product's nutritional and bioactive profile.
2Quantity of substance
If current manufacturing processes are used for infant formula, then production is scalable, but the composition cannot replicate human milk's complex components
Solution Approach 1:
The patent utilizes the self-service capability of living breast milk stem cells to automatically produce complex milk components. The cultured mammary cells autonomously synthesize proteins, lipids, carbohydrates, and bioactive factors with proper structural complexity and functional activity, achieving high compositional precision that conventional manufacturing cannot replicate.
Solution Approach 2:
The patent creates a composite biological system by culturing stem cells that naturally produce the complex mixture of milk components. This biological composite approach generates authentic human milk-like composition with multiple interacting components (proteins, lipids, carbohydrates, bioactives) rather than simple synthetic mixtures.
3Device complexity
If breast milk stem cells are cultured without BMP4 and RA, then the culture process is simpler, but differentiation efficiency into mammary gland cells is reduced
Solution Approach 1:
The patent applies preliminary action by pre-programming the differentiation pathway through timed addition of BMP4 and retinoic acid during specific stages of stem cell culture. This preliminary guidance of cell fate determination ensures high differentiation efficiency into functional mammary cells while maintaining a relatively simple overall culture protocol.
Data Source
AI summary
A method for producing mammary gland cells and a method of producing a mammalian milk like product, for example a human milk like product, comprising generating lactocytes derived from mammalian adult breast milk stem cells (mBSC), for example from human adult breast milk stem cells (hBSC) and expressing the mammalian milk like product, for example the human milk like product from lactocytes.